PortfoliosLab logoPortfoliosLab logo
ESEA vs. XBI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ESEA vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Euroseas Ltd (ESEA) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ESEA achieves a 34.50% return, which is significantly higher than XBI's 24.78% return. Over the past 10 years, ESEA has outperformed XBI with an annualized return of 25.26%, while XBI has yielded a comparatively lower 10.37% annualized return.


ESEA

1D
0.39%
1M
3.30%
6M
33.16%
YTD
34.50%
1Y
54.30%
3Y*
85.78%
5Y*
51.36%
10Y*
25.26%

XBI

1D
-2.70%
1M
12.42%
6M
22.36%
YTD
24.78%
1Y
73.87%
3Y*
21.27%
5Y*
3.96%
10Y*
10.37%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ESEA vs. XBI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ESEA
Euroseas Ltd
34.50%140.95%23.60%83.39%-21.02%358.75%33.42%-27.32%-58.82%0.59%
XBI
SPDR S&P Biotech ETF
24.78%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-15.28%43.77%

Correlation

The correlation between ESEA and XBI is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.16

Correlation (All Time)
Calculated using the full available price history since May 5, 2006

0.18

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ESEA vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ESEA
ESEA Risk / Return Rank: 8080
Overall Rank
ESEA Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
ESEA Sortino Ratio Rank: 7575
Sortino Ratio Rank
ESEA Omega Ratio Rank: 7676
Omega Ratio Rank
ESEA Calmar Ratio Rank: 8686
Calmar Ratio Rank
ESEA Martin Ratio Rank: 8282
Martin Ratio Rank

XBI
XBI Risk / Return Rank: 9393
Overall Rank
XBI Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 9292
Sortino Ratio Rank
XBI Omega Ratio Rank: 8888
Omega Ratio Rank
XBI Calmar Ratio Rank: 9696
Calmar Ratio Rank
XBI Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ESEA vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Euroseas Ltd (ESEA) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ESEAXBIDifference
Sharpe ratioReturn per unit of total volatility

-1.55

Sortino ratioReturn per unit of downside risk

-1.84

Omega ratioGain probability vs. loss probability

1.24

1.43

-0.20

Calmar ratioReturn relative to maximum drawdown

2.97

7.64

-4.67

Martin ratioReturn relative to average drawdown

5.94

22.09

-16.16

ESEA vs. XBI - Sharpe Ratio Comparison

The current ESEA Sharpe Ratio is 1.25, which is lower than the XBI Sharpe Ratio of 2.79. The chart below compares the historical Sharpe Ratios of ESEA and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ESEA vs. XBI - Drawdown Comparison

The maximum ESEA drawdown since its inception was -99.84%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for ESEA and XBI.


Loading charts...

Drawdown Indicators


ESEAXBIDifference

Max Drawdown

Largest peak-to-trough decline

-99.84%

-63.89%

-35.95%

Max Drawdown (1Y)

Largest decline over 1 year

-18.36%

-9.72%

-8.64%

Max Drawdown (3Y)

Largest decline over 3 years

-38.00%

-32.99%

-5.01%

Max Drawdown (5Y)

Largest decline over 5 years

-51.28%

-54.00%

+2.72%

Max Drawdown (10Y)

Largest decline over 10 years

-95.54%

-63.89%

-31.65%

Current Drawdown

Current decline from peak

-86.34%

-12.06%

-74.28%

Average Drawdown

Average peak-to-trough decline

-85.41%

-20.89%

-64.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.18%

3.35%

+5.83%

Volatility

ESEA vs. XBI - Volatility Comparison

The current volatility for Euroseas Ltd (ESEA) is 6.61%, while SPDR S&P Biotech ETF (XBI) has a volatility of 8.50%. This indicates that ESEA experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ESEAXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.61%

8.50%

-1.89%

Volatility (6M)

Calculated over the trailing 6-month period

32.88%

21.51%

+11.37%

Volatility (1Y)

Calculated over the trailing 1-year period

43.81%

26.65%

+17.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

54.49%

32.33%

+22.16%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

94.32%

31.93%

+62.39%

Dividends

ESEA vs. XBI - Dividend Comparison

ESEA's dividend yield for the trailing twelve months is around 4.11%, more than XBI's 0.38% yield.


PositionTTM20252024202320222021202020192018201720162015
ESEA
Euroseas Ltd
4.11%16.23%6.63%6.42%8.13%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF
0.38%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%

Frequently Asked Questions


ESEA and XBI have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XBI has higher volatility (8.50%) compared to ESEA (6.61%). In terms of maximum drawdown, ESEA dropped -99.84% vs XBI's -63.89%.

XBI currently has the higher Sharpe Ratio (2.79 vs 1.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ESEA and XBI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer